Saturday, June 5, 2010

Detecting XMRV antibodies

VIP Dx received confirmation from representatives of the Whittemore Peterson Institute (WPI) that a multiplex serological assay to detect XMRV antibodies should be available for use within the next 30 days.

“This serological test will allow our lab to quickly and accurately determine which individuals are positive for XMRV,” explained Marguerite Ross, director of marketing and client relations for VIP Dx. “Discovering who is positive is an important first step in helping to determine how XMRV is impacting human health.”

VIP Dx has also recently entered into an agreement to be acquired by the Whittemore Peterson Institute, and become an integral part of the Institute. The clinical laboratory will continue to operate under the name VIP Dx, until it moves to the University of Nevada's Center for Molecular Medicine in August 2010.

At that time, the lab will operate within the Institute under the name Unevx, providing services and revenue to the Institute in a manner similar to other institutional clinical reference laboratories.

"Our agreement to acquire VIP Dx is the culmination of years of planning and sacrifice,” said Annette Whittemore, president and founder of the Whittemore Peterson Institute. "It has always been our intent to offer a wide range of patient services, including diagnostic testing, within WPI’s new facility at the University of Nevada, Reno. The addition of comprehensive clinical laboratory services will significantly strengthen the translational clinical research program providing much needed answers to patients and their doctors."

Finally, in response to thousands of requests for testing, WP Biotechnologies (WPBio), a wholly owned subsidiary of the Whittemore Peterson Institute, finalized a non-exclusive license agreement with R.E.D. Laboratories N.V. of Belgium (R.E.D. Labs) to provide XMRV testing of European patients.

As part of this agreement, R.E.D. Labs will receive consulting services delivered by VIP Dx to ensure the Belgium laboratory delivers the proprietary tests with the utmost accuracy. “This activity will help implement the delivery and execution of XMRV tests by virus culture for patients all across Europe, using the WPI technology,” said Carli West Kinne, director of WPBio. “The European market is a significant part of our plan to move the work of the WPI forward on behalf of those who are ill.”

1 comment:

Cinq said...

A foremost expert on CFS, Dr. Jacob Teitelbaum, has just put out a new book called Beat Sugar Addiction Now: http://endfatigue.com/. It is written in a simple style and outlines his easy to follow, multi-step plan. He begins by identifying 4 main types of sugar addicts and then outlines a specific plan for each type of addict to follow. He explains how sugar plays into the problems suffered by each kind of addict and goes into detail when clearly and succinctly explaining how to beat the cravings. While Teitelbaum does not provide recipes or meal plans, he does give guidelines for healthy eating and lists of recommended foods as well as the glycemic index for many common foods.This book would probably be helpful not only to people attempting to lose weight, but also to those with illnesses such as Type II Diabetes, Fibromyalgia, and Chronic Fatigue Syndrome, just to name a few. Though Teitelbaum is a medical doctor and is clearly coming from a medical background, he writes in layman's terms and creates a book that will be easily understood by most people.

LinkWithin

Related Posts with Thumbnails